Cardiovascular Health

Session presenters at ASCP 2022 Annual Meeting discuss the benefits and disadvantages of apixaban versus warfarin for anticoagulation.

However, findings do not preclude the possibility that mechanisms other than cardiac remodeling may be responsible for benefits of SGLT2 inhibition.

Approximately 10% of patients in trial experienced a heart attack, stroke, blocked arteries requiring treatment, or death from cardiovascular disease.

Chlorthalidone was associated with more individuals with potassium levels below 3.1 mmol/L, suggesting a greater risk of hypokalemia.

Controlling blood pressure may be the most important type of treatment for vasculitis and lupus patients, said a professor of renal medicine at ASN Kidney Week in Orlando, Florida.

In addition to the ongoing COVID-19 pandemic, significant public health concerns include opioid overdoses, maternal mortality disparities, and climate change.

FDA Commissioner Robert Califf said that misinformation is the most common cause of death in the United States.

It may be worth considering the pathophysiology and vascular complications of chemotherapy, especially among patients who are already hypertensive.

Among nicotine users, there was an approximately 4 beat per minute jump in heart rate after vaping or smoking.

Chronic hypertension during pregnancy increases the risk of poor pregnancy and birth outcomes.

ASCP 2022 session presenters review the evidence that tipped the scales against the use of aspirin for primary prevention in patients aged 60 years or older.

ASCP 2022 session presenters discuss medications that can cause QTc prolongation, with a particular emphasis on a review of the literature with regards to QTc prolongation and antipsychotics.

In patients with hypoxic-ischemic brain injury, researchers observed no significant difference between liberal and restrictive oxygenation on any-cause death.

The treatment modulates the number of myosin heads that can enter “on actin” states and lowers the probability of force-producing (systolic) and residual (diastolic) cross-bridge formation.

New research suggests that high levels of an immune protein in kidney disease might be able to predict risk of heart failure or death by reflecting the upstream process of stress.

Previous studies have shown that PAD also impacts health status and functioning.

The drug shows improvement in exercise capacity and key secondary outcomes compared with the placebo when added to background therapy for those with pulmonary arterial hypertension.

Treating patients with rivaroxaban resulted in 32.5 fewer symptomatic venous thromboembolism (VTE) and VTE-related deaths among 10,000 patients.

The American College of Chest Physicians' update of its CHEST guidelines for the treatment of VTE includes 29 guidance statements.

Women with a history of gestational diabetes had a 45% increased risk of overall cardiovascular and cerebrovascular diseases.

The incremental use of drug combinations could prevent hospitalizations from heart failure among those who have higher ejection farction, a subgroup that struggles with insufficient data on treatments.

For patients suffering from a higher left ventricular ejection fraction, a sodium-glucose cotransporter 2 inhibitor could decrease risk of hospitalization or death from heart failure.

Study finds that 13% of all heart-related emergency department visits were related to essential hypertension.

Pharmacist education also helps prevent adverse reactions, maximizes outcomes for the symptomless disease.

Excess drinking is a major atrial fibrillation risk factor in young people.